Cargando…

The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study

BACKGROUND: The time in therapeutic range values may vary between different geographical regions of Turkey in patients vitamin K antagonist therapy. AIMS: To evaluate the time in therapeutic range percentages, efficacy, safety and awareness of warfarin according to the different geographical regions...

Descripción completa

Detalles Bibliográficos
Autores principales: Kılıç, Salih, Çelik, Ahmet, Çakmak, Hüseyin Altuğ, Afşin, Abdülmecit, Tekkeşin, Ahmet İlker, Açıksarı, Gönül, Memetoğlu, Mehmet Erdem, Özpamuk Karadeniz, Fatma, Şahan, Ekrem, Alıcı, Mehmet Hayri, Dereli, Yüksel, Sinan, Ümit Yaşar, Zoghi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615968/
https://www.ncbi.nlm.nih.gov/pubmed/28443575
http://dx.doi.org/10.4274/balkanmedj.2016.1617
_version_ 1783266701346865152
author Kılıç, Salih
Çelik, Ahmet
Çakmak, Hüseyin Altuğ
Afşin, Abdülmecit
Tekkeşin, Ahmet İlker
Açıksarı, Gönül
Memetoğlu, Mehmet Erdem
Özpamuk Karadeniz, Fatma
Şahan, Ekrem
Alıcı, Mehmet Hayri
Dereli, Yüksel
Sinan, Ümit Yaşar
Zoghi, Mehdi
author_facet Kılıç, Salih
Çelik, Ahmet
Çakmak, Hüseyin Altuğ
Afşin, Abdülmecit
Tekkeşin, Ahmet İlker
Açıksarı, Gönül
Memetoğlu, Mehmet Erdem
Özpamuk Karadeniz, Fatma
Şahan, Ekrem
Alıcı, Mehmet Hayri
Dereli, Yüksel
Sinan, Ümit Yaşar
Zoghi, Mehdi
author_sort Kılıç, Salih
collection PubMed
description BACKGROUND: The time in therapeutic range values may vary between different geographical regions of Turkey in patients vitamin K antagonist therapy. AIMS: To evaluate the time in therapeutic range percentages, efficacy, safety and awareness of warfarin according to the different geographical regions in patients who participated in the WARFARIN-TR study (The Awareness, Efficacy, Safety and Time in Therapeutic Range of Warfarin in the Turkish population) in Turkey. STUDY DESIGN: Cross-sectional study. METHODS: The WARFARIN-TR study includes 4987 patients using warfarin and involved regular international normalized ratio monitoring between January 1, 2014 and December 31, 2014. Patients attended follow-ups for 12 months. The sample size calculations were analysed according to the density of the regional population and according to Turkish Statistical Institute data. The time in therapeutic range was calculated according to F.R. Roosendaal’s algorithm. Awareness was evaluated based on the patients’ knowledge of the effect of warfarin and food-drug interactions with simple questions developed based on a literature review. RESULTS: The Turkey-wide time in therapeutic range was reported as 49.5%±22.9 in the WARFARIN-TR study. There were statistically significant differences between regions in terms of time in therapeutic range (p<0.001). The highest rate was reported in the Marmara region (54.99%±20.91) and the lowest was in the South-eastern Anatolia region (41.95±24.15) (p<0.001). Bleeding events were most frequently seen in Eastern Anatolia (41.6%), with major bleeding in the Aegean region (5.11%) and South-eastern Anatolia (5.36%). There were statistically significant differences between the regions in terms of awareness (p<0.001). CONCLUSION: Statistically significant differences were observed in terms of the efficacy, safety and awareness of warfarin therapy according to different geographical regions in Turkey.
format Online
Article
Text
id pubmed-5615968
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-56159682017-10-02 The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study Kılıç, Salih Çelik, Ahmet Çakmak, Hüseyin Altuğ Afşin, Abdülmecit Tekkeşin, Ahmet İlker Açıksarı, Gönül Memetoğlu, Mehmet Erdem Özpamuk Karadeniz, Fatma Şahan, Ekrem Alıcı, Mehmet Hayri Dereli, Yüksel Sinan, Ümit Yaşar Zoghi, Mehdi Balkan Med J Original Article BACKGROUND: The time in therapeutic range values may vary between different geographical regions of Turkey in patients vitamin K antagonist therapy. AIMS: To evaluate the time in therapeutic range percentages, efficacy, safety and awareness of warfarin according to the different geographical regions in patients who participated in the WARFARIN-TR study (The Awareness, Efficacy, Safety and Time in Therapeutic Range of Warfarin in the Turkish population) in Turkey. STUDY DESIGN: Cross-sectional study. METHODS: The WARFARIN-TR study includes 4987 patients using warfarin and involved regular international normalized ratio monitoring between January 1, 2014 and December 31, 2014. Patients attended follow-ups for 12 months. The sample size calculations were analysed according to the density of the regional population and according to Turkish Statistical Institute data. The time in therapeutic range was calculated according to F.R. Roosendaal’s algorithm. Awareness was evaluated based on the patients’ knowledge of the effect of warfarin and food-drug interactions with simple questions developed based on a literature review. RESULTS: The Turkey-wide time in therapeutic range was reported as 49.5%±22.9 in the WARFARIN-TR study. There were statistically significant differences between regions in terms of time in therapeutic range (p<0.001). The highest rate was reported in the Marmara region (54.99%±20.91) and the lowest was in the South-eastern Anatolia region (41.95±24.15) (p<0.001). Bleeding events were most frequently seen in Eastern Anatolia (41.6%), with major bleeding in the Aegean region (5.11%) and South-eastern Anatolia (5.36%). There were statistically significant differences between the regions in terms of awareness (p<0.001). CONCLUSION: Statistically significant differences were observed in terms of the efficacy, safety and awareness of warfarin therapy according to different geographical regions in Turkey. Galenos Publishing 2017-07 2017-08-04 /pmc/articles/PMC5615968/ /pubmed/28443575 http://dx.doi.org/10.4274/balkanmedj.2016.1617 Text en © Copyright 2017, Trakya University Faculty of Medicine http://creativecommons.org/licenses/by/2.5/ Balkan Medical Journal
spellingShingle Original Article
Kılıç, Salih
Çelik, Ahmet
Çakmak, Hüseyin Altuğ
Afşin, Abdülmecit
Tekkeşin, Ahmet İlker
Açıksarı, Gönül
Memetoğlu, Mehmet Erdem
Özpamuk Karadeniz, Fatma
Şahan, Ekrem
Alıcı, Mehmet Hayri
Dereli, Yüksel
Sinan, Ümit Yaşar
Zoghi, Mehdi
The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
title The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
title_full The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
title_fullStr The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
title_full_unstemmed The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
title_short The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
title_sort time in therapeutic range and bleeding complications of warfarin in different geographic regions of turkey: a subgroup analysis of warfarin-tr study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615968/
https://www.ncbi.nlm.nih.gov/pubmed/28443575
http://dx.doi.org/10.4274/balkanmedj.2016.1617
work_keys_str_mv AT kılıcsalih thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT celikahmet thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT cakmakhuseyinaltug thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT afsinabdulmecit thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT tekkesinahmetilker thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT acıksarıgonul thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT memetoglumehmeterdem thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT ozpamukkaradenizfatma thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT sahanekrem thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT alıcımehmethayri thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT dereliyuksel thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT sinanumityasar thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT zoghimehdi thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT kılıcsalih timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT celikahmet timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT cakmakhuseyinaltug timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT afsinabdulmecit timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT tekkesinahmetilker timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT acıksarıgonul timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT memetoglumehmeterdem timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT ozpamukkaradenizfatma timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT sahanekrem timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT alıcımehmethayri timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT dereliyuksel timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT sinanumityasar timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy
AT zoghimehdi timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy